Showing 1,241 - 1,260 results of 1,357 for search '"myocardial"', query time: 0.06s Refine Results
  1. 1241

    Cardiovascular Profile and Cardiovascular Imaging After Bariatric Surgery: A Narrative Review by Mihaela Toader, Liliana Gheorghe, Costin Chirica, Ionuț-Alexandru Ghicu, Sabina-Ioana Chirica, Andreea Isabela Mazga, Danisia Haba, Mădălina Maxim, Ancuța Andreea Miler, Daniela Crișu, Mihai Ștefan Cristian Haba, Daniel Vasile Timofte

    Published 2025-01-01
    “…<i>Results</i>: BaS has been found to be strongly associated with a reduced incidence of severe complications in individuals with a history of myocardial infarction (MI) and severe obesity. Specifically, this procedure is linked to a lower occurrence of major adverse cardiovascular events and a decrease in overall mortality. …”
    Get full text
    Article
  2. 1242

    Metallothioneins 1 and 2 Modulate Inflammation and Support Remodeling in Ischemic Cardiomyopathy in Mice by Georg D. Duerr, Daniela Dewald, Eva J. Schmitz, Luise Verfuerth, Katharina Keppel, Christine Peigney, Alexander Ghanem, Armin Welz, Oliver Dewald

    Published 2016-01-01
    “…Cardioprotective effects of MT1/2 seem to be exerted via modulation of contractile elements, antioxidative enzymes, inflammatory response, and myocardial remodeling.…”
    Get full text
    Article
  3. 1243

    Increased indexed proximal aortic diameter is a predictor of poor prognosis in maintenance hemodialysis patients by Junwei Xu, Wenyi Tang, Lizheng Song, Yuxi Huang, Li Xiao, Fangyuan Cheng, Qianglin Guan, Mei Xu, Chuoxin Ma, Jian Chen, Jianting Ke

    Published 2024-12-01
    “…The secondary endpoint was major adverse cardiovascular events (MACE), including cardiovascular mortality, myocardial infarction and stroke. Cox proportional hazards models were conducted to evaluate the association between baseline ARD/BSA and clinical outcomes.Results A total of 391 patients were included in this study. …”
    Get full text
    Article
  4. 1244

    TLR4 Inhibition Attenuated LPS‐Induced Proinflammatory Signaling and Cytokine Release in Mouse Hearts and Cardiomyocytes by Christine W. Wiger, Trine Ranheim, Henriette Arnesen, Jarle Vaage, Søren E. Pischke, Arne Yndestad, Kåre‐Olav Stensløkken, May‐Kristin Torp

    Published 2025-01-01
    “…ABSTRACT Background Sepsis is associated with myocardial injury and early mortality. The innate immune receptor Toll‐like receptor 4 (TLR4) can recognize pathogen‐associated‐molecular‐patterns (PAMPs) and damage‐associated molecular patterns (DAMPs); the latter are released during tissue injury. …”
    Get full text
    Article
  5. 1245

    Isolated Adrenocorticotropin Deficiency Associated with Delirium and Takotsubo Cardiomyopathy by Masanori Murakami, Noriko Matsushita, Rie Arai, Naohiro Takahashi, Ryuki Kawamura, Sayaka Suzuki, Sachio Takekawa, Fumiko Iwashima, Takashi Shibui, Akihiro Hata, Yoshihiro Ogawa, Toshiyuki Horiuchi

    Published 2012-01-01
    “…We conclude that her unstable mental state and myocardial dysfunction were closely related to adrenal insufficiency and suggest that adrenal crisis may cause delirium and Takotsubo cardiomyopathy.…”
    Get full text
    Article
  6. 1246

    Extracellular Recordings of Patterned Human Pluripotent Stem Cell-Derived Cardiomyocytes on Aligned Fibers by Junjun Li, Itsunari Minami, Leqian Yu, Kiyotaka Tsuji, Minako Nakajima, Jing Qiao, Masato Suzuki, Ken Shimono, Norio Nakatsuji, Hitetoshi Kotera, Li Liu, Yong Chen

    Published 2016-01-01
    “…Human induced pluripotent stem cell (hiPSC) derived cardiomyocytes (CMs) hold high potential for use in drug assessment and myocardial regeneration. To create tissue-like constructs of CMs for extracellular monitoring, we placed aligned fibers (AFs) on the surface of a microelectrode array and then seeded hiPSC-CMs for subsequent monitoring for 14 days. …”
    Get full text
    Article
  7. 1247

    Emergency interventions for cardiogenic shock due to decompensated aortic stenosis: a systematic review and meta-analysis by Mauro Chiarito, Dario Bongiovanni, Evaldas Girdauskas, Bastian Wein, Eva Harmel, Tamer Owais, Stephanie Gladys Kühne, Andrea Patrignani, Sebastien Elvinger, Damyan Penev, Philip W Raake

    Published 2025-01-01
    “…Secondary endpoints were in-hospital mortality, 1-year mortality, bleeding, major vascular complications, myocardial infarction, stroke, incidence of pacemaker implantation, acute kidney injury and aortic regurgitation.Results Seventeen studies were included, totalling 2811 patients. …”
    Get full text
    Article
  8. 1248

    Comparison of Mortality Risk Models in Patients with Postcardiac Arrest Cardiogenic Shock and Percutaneous Mechanical Circulatory Support by Georgios Chatzis, Birgit Markus, Styliani Syntila, Christian Waechter, Ulrich Luesebrink, Holger Ahrens, Dimitar Divchev, Bernhard Schieffer, Konstantinos Karatolios

    Published 2021-01-01
    “…Although scoring systems are widely used to predict outcomes in postcardiac arrest cardiogenic shock (CS) after out-of-hospital cardiac arrest (OHCA) complicating acute myocardial infarction (AMI), data concerning the accuracy of these scores to predict mortality of patients treated with Impella in this setting are lacking. …”
    Get full text
    Article
  9. 1249

    Post Covid-19 Syndromes, The Time line of Covid by Nadia Shams, Zaid Umar, Lubna Meraj, Neelam Ayub, Muhammad Waseem, Kazim Abbas Virk

    Published 2023-01-01
    “…In CVS, retrosternal chest pain in 11, orthopnea/PND 05, myocarditis/myocardial fibrosis 04, pericardial effusion 01, new onset hypertension 03, worsened hypertensive control 02, palpitations 10 and POTS 03. …”
    Get full text
    Article
  10. 1250

    Primary Angioplasty in a Catastrophic Presentation: Acute Left Main Coronary Total Occlusion—The ATOLMA Registry by A. Gutiérrez-Barrios, L. Gheorghe, S. Camacho-Freire, F. Valencia-Serrano, D. Cañadas-Pruaño, G. Calle-Pérez, I. Alarcón de la Lastra, E. Silva, D. García-Molinero, A. Agarrado-Luna, R. Zayas-Ruedas, R. Vázquez-García, A. Serra

    Published 2020-01-01
    “…This is a multicenter retrospective cohort that includes patients presenting with myocardial infarction due to a confirmed ATOLMA who underwent emergency percutaneous coronary intervention (PCI). …”
    Get full text
    Article
  11. 1251

    Atrial fibrillation in acute coronary syndrome: clinical and anamnestic features and effects on the course by V.І. Tseluyko, F.B. Salem, N.A. Lopina, I.V. Kuznetsov

    Published 2019-03-01
    “…The aim – to determine the clinical and anamnestic parameters associated with development of atrial fibrillation (AF) in patients with acute coronary syndrome (ACS) and to assess the impact of this rhythm disorder on the course of myocardial infarction in the hospital period. Materials and methods. …”
    Get full text
    Article
  12. 1252

    Protective Effects of NaHS/miR-133a-3p on Lipopolysaccharide-Induced Cardiomyocytes Injury by Yi-Mei Jin, Ai-Rong Huang, Mei-qian Yu, Wan-Ding Ye, Xiao-guang Hu, Hua-min Wang, Zhi-wei Xu, Dong-shi Liang

    Published 2023-01-01
    “…Our research demonstrated that NaHS relieved LPS-induced myocardial injury in H9c2 by promoting the expression of miR-133a-3p, inhibiting autophagy in cardiomyocytes, and restoring cellular ATP levels.…”
    Get full text
    Article
  13. 1253
  14. 1254

    Biomedical and candidate SN P markers of chronopathologies can significantly change affinity of ТАТА -binding protein for human gene promoters by D. A. Rasskazov, N. L. Podkolodnyy, O. A. Podkolodnaya, N. N. Podkolodnaya, V. V. Suslov, L. K. Savinkova, P. M. Ponomarenko, M. P. Ponomarenko

    Published 2016-01-01
    “…In the [–70; –20] region of promoters of 14 human genes (location of proven binding sites of ТВР), we found 32 known and candidate SNP markers of circadian- rhythm disturbances, including rs17231520 and rs569033466 (both: risk of chronopathologies in liver); rs35036378 (behavioral chronoaberrations); rs549858786 (rheumatoid arthritis with a chronoaberration of IL1B expression); rs563207167, rs11557611, and rs5505 (all three: chronopathologies of the tumor – host balance, blood pressure, and the reproductive system); rs1143627 (bipolar disorder with circadian dependence of diagnosis and treatment); rs16887226 and rs544850971 (both: lowered resistance to endotoxins because of the imbalance between the circadian and immune systems); rs367732974 and rs549591993 (both: circadian dependence of heart attacks); rs563763767 (circadian dependence of myocardial infarction); rs2276109 and rs572527200 (both: circadian dependence of asthma attacks); rs34223104, rs563558831, and rs10168 (circadian optima of treatment with methotrexate and cyclophosphamide); and rs397509430, rs33980857,rs34598529, rs33931746, rs33981098, rs34500389, rs63750953, rs281864525, rs35518301, and rs34166473 (all: neurosensory hearing loss and restless legs syndrome). …”
    Get full text
    Article
  15. 1255

    Predicting cardiovascular outcomes in Chinese patients with type 2 diabetes by combining risk factor trajectories and machine learning algorithm: a cohort study by Qi Huang, Xiantong Zou, Zhouhui Lian, Xianghai Zhou, Xueyao Han, Yingying Luo, Shuohua Chen, Yanxiu Wang, Shouling Wu, Linong Ji

    Published 2025-02-01
    “…Using baseline characteristics and changes over a four-year observation period, we developed the ML-CVD-C (Machine Learning Cardiovascular Disease in Chinese) score to predict 10-year cardiovascular risk, including cardiovascular death, nonfatal myocardial infarction, and stroke. We compared the discrimination and calibration of ML-CVD-C with models using only baseline variables (ML-CVD-C [base]), China-PAR (Prediction for ASCVD Risk in China), and PREVENT (Predict Risk of cardiovascular disease EVENTs). …”
    Get full text
    Article
  16. 1256

    Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice by Jing Ye, Ling Liu, Qingwei Ji, Ying Huang, Ying Shi, Lei Shi, Jianfang Liu, Menglong Wang, Yao Xu, Huimin Jiang, Zhen Wang, Yingzhong Lin, Jun Wan

    Published 2017-01-01
    “…In addition, angiotensin II-treated mice received an injection of anti-IL-22-neutralizing antibody (nAb) to investigate the effects of IL-22 nAb on myocardial hypertrophy, cardiac function, and cardiac fibrosis; the activation of the signaling pathway and the prohypertrophic inflammatory cytokine mRNA levels was detected. …”
    Get full text
    Article
  17. 1257

    A murine model of Trypanosoma brucei-induced myocarditis and cardiac dysfunction by Nathan P. Crilly, Marcelle Dina Zita, Alexander K. Beaver, Polina Sysa-Shah, Aashik Bhalodia, Kathy Gabrielson, Luigi Adamo, Monica R. Mugnier

    Published 2025-02-01
    “…On flow cytometry, myocarditis was associated with an increase of most myocardial immune cell populations, including multiple T cell and macrophage subsets, corroborating the notion that T. brucei-associated cardiac damage is an immune-mediated event. …”
    Get full text
    Article
  18. 1258

    Clinical Implications of Bifurcation Angles in Left Main Bifurcation Intervention Using a Two-Stent Technique by You-Jeong Ki, Ji Hyun Jung, Jung-Kyu Han, Sukkeun Hong, Jang Hyun Cho, Hyeon-Cheol Gwon, Sung Yun Lee, Jay Young Rhew, Jei Keon Chae, In-Ho Chae, Han-Mo Yang, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo, Hyo-Soo Kim

    Published 2020-01-01
    “…The primary outcome was target lesion failure (TLF), a composite of cardiac death, myocardial infarction, and target lesion revascularization (TLR). …”
    Get full text
    Article
  19. 1259

    Efferocytosis and inflammation: a bibliometric and systematic analysis by Xin Cao, Xin Cao, Fen Li, Fen Li, Xi Xie, Xi Xie, Guanghui Ling, Guanghui Ling, Xiaoyu Tang, Xiaoyu Tang, Wenfang He, Jing Tian, Jing Tian, Yan Ge, Yan Ge

    Published 2025-02-01
    “…Keyword analysis identified “activation,” “tam receptors,” “docosahexaenoic acid” “systemic lupus erythematosus,” “myocardial infarction” and “alveolar macrophages” as core topics, indicating a concentrated trend in the mechanism of physiological state and inflammatory diseases such as autoimmune, cardiovascular, and pulmonary diseases. …”
    Get full text
    Article
  20. 1260

    From bench to bedside: elucidating VEGF(R) inhibitor-related heart failure in cancer treatment by Shengkun Peng, MinHong Cai, Hongyu Kuang, Anqi Lin, Qinghua Ma, Xiaoqin Dai, Peng Luo, Yijun Liu, Guo Zhang, Yifeng Bai

    Published 2025-01-01
    “…Experimental studies in mice revealed that both acute and chronic VEGF(R)i administration resulted in reduced left ventricular EF, cardiomyocyte hypertrophy, and myocardial fibrosis. Transcriptomic analysis identified significant dysregulation of multiple key signaling pathways, including DNA repair (R = 0.46), mitochondrial ATP synthesis (R = 0.39), glycogen metabolism regulation (R = 0.45), and proteasome-mediated protein degradation (R = 0.45). …”
    Get full text
    Article